49 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
3 Reasons Pharma Stocks Are a Buy Right Now https://www.fool.com/investing/2020/03/25/3-reasons-pharma-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 25, 2020 - The coronavirus outbreak has made shares of top drugmakers more attractive than they've been in a quite a while.
Agios' IND for PKR Activator AG-946 Gets FDA Clearance http://www.zacks.com/stock/news/832392/agios-ind-for-pkr-activator-ag-946-gets-fda-clearance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-832392 Mar 24, 2020 - The FDA passes Agios' (AGIO) investigational new drug application for its next-generation PKR activator, AG-946. The company plans to begin a phase I study on the same in mid-2020.
Pfizer's Eczema Drug Eucrisa Gets FDA Approval for Infants http://www.zacks.com/stock/news/834155/pfizers-eczema-drug-eucrisa-gets-fda-approval-for-infants?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-834155 Mar 25, 2020 - Pfizer (PFE) gets FDA approval for label expansion of Eucrisa to include children aged three months to two years with mild-to-moderate atopic dermatitis or eczema.
Eli Lilly Licenses Immunology Drugs for Up to $880 Million https://www.fool.com/investing/2020/03/31/eli-lilly-licenses-immunology-drugs-for-up-to-880.aspx?source=iedfolrf0000001 Mar 31, 2020 - The pharma giant will develop and market up to four drugs from the pipeline of privately-held Sitryx.
Buy this High-Yield Large Cap Pharma Stock for Income Amid Coronavirus http://www.zacks.com/stock/news/847731/buy-this-high-yield-large-cap-pharma-stock-for-income-amid-coronavirus?cid=CS-ZC-FT-video_blog-847731 Mar 31, 2020 - AbbVie (ABBV) stock popped on Tuesday. This is part of the global pharmaceutical giant's larger 20% surge in the last week as the market tries to mount a comeback amid the coronavirus uncertainty...
3 Drugmakers Still Worth Betting on Amid Coronavirus Woes http://www.zacks.com/stock/news/849056/3-drugmakers-still-worth-betting-on-amid-coronavirus-woes?cid=CS-ZC-FT-analyst_blog|investment_ideas-849056 Apr 01, 2020 - Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.
3 Stocks Immune to the Coronavirus Downturn to Buy Right Now http://www.zacks.com/stock/news/857564/3-stocks-immune-to-the-coronavirus-downturn-to-buy-right-now?cid=CS-ZC-FT-zacks_friday_finish_line-857564 Apr 06, 2020 - Today's episode of Full Court Finance here at Zacks quickly dives into why Wall Street seems optimistic on Monday. Despite the positivity, investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout...
5 Low-Risk Stocks to Buy for Epic Price Swings Since 1929 http://www.zacks.com/stock/news/860620/5-low-risk-stocks-to-buy-for-epic-price-swings-since-1929?cid=CS-ZC-FT-analyst_blog|investment_ideas-860620 Apr 08, 2020 - The S&P 500's average daily percentage price change over the past five weeks has been plus or minus 4.8%. This explains why the Cboe Volatility Index remains elevated at around the 40s.
5 Stocks With Recent Price Strength Amid Coronavirus Logjam http://www.zacks.com/stock/news/862418/5-stocks-with-recent-price-strength-amid-coronavirus-logjam?cid=CS-ZC-FT-analyst_blog|rw-862418 Apr 09, 2020 - Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Eli Lilly Starts Clinical Trial for Potential COVID-19 Treatment https://www.fool.com/investing/2020/04/11/eli-lilly-starts-clinical-trial-for-potential-covi.aspx?source=iedfolrf0000001 Apr 11, 2020 - The pharma company believes that its rheumatoid arthritis treatment Olumiant could be effective at treating COVID-19 patients.

Pages: 12345

Page 1>